Fatma Burcu SEVINC

Accomplished healthcare professional with extensive expertise in clinical judgement, patient consultations, and compassionate patient care. Demonstrates exceptional skills in verbal communication, supervision and leadership, and strategic leadership within primary care environments. Proficient in Microsoft Office and medical software data entry, with a strong focus on ethical integrity and patient data confidentiality. Adept at managing clinical emergencies and providing advanced life support, while maintaining calm under pressure. Committed to best medical practice principles and continuous improvement in client relationship management. Experienced healthcare professional focused on providing high-quality patient care and medical expertise. Drive positive patient outcomes through comprehensive diagnosis, treatment planning, and patient education. Leverage strong communication skills and collaborative approach to enhance interdisciplinary teamwork and healthcare delivery. Offering strong analytical skills, effective communication, and compassionate approach to patient care. Knowledgeable about medical protocols and eager to contribute to collaborative healthcare environment. Ready to use and develop diagnostic abilities, patient interaction, and teamwork skills in any current role.

• Occupational doctor certificate, 07/01/16
• Traditional and Complementary Medicine Training, 03/01/20
• 56th National Diabetes Congress – metabolism and Nutritional Diseases, 06/01/20
• 9th Gastroenterological Surgery Congress, 05/01/21
• European Congress of Internal Medicine (ECIM), 04/01/24
• ERC ALS course, 05/01/24
• Obesity and non-invasive respiratory support Workshops, 04/01/24
• Hair Transplant Restoration Techniques, 10/01/24
• Ozone Therapy Techniques, 11/01/24
• Training program in IV Drip Therapy, specializing in NAD+ and antioxidant vitamin infusions, 12/01/24

• Diagnostic and prognostic utility of INSM1, ISL1 and secretagogin in pheochromocytoma, 11/01/23, To assess immunohistochemical expression of the second generation neuroendocrine immunohistochemical markers such as insulin gene enhancer protein 1 (ISL1), insulinoma-associated protein 1 (INSM1) and secretagogin (SECG) in pheochromocytoma (PCC) and prognostic value., INSM1, ISL1 and SECG, which are second generation neuroendocrine immunohistochemical markers, can be used in the differential diagnosis of pheochromocytoma. ISNM1 may have prognostic significance.
• The effect of anti-TNF treatment on bone mineral density in patients with ankylosing spondylitis, 01/01/24, Evaluate anti-TNF on Daily bone density in AS patients. Our secondary aim is to examine the changes in vitamin D levels, calcium, phosphorus, PTH, ALP, ESH and CRP levels after anti-TNF treatment., After anti-TNF treatment we detected significant improvement on bone mineral density, disease activity indexes and patients' functional status.
• Endocrinology, Evaluation of Inflammation of Inflammation-related Hemogram Parameters as a useful marker in Papillary Thyroid Carcinoma, 02/09/22, Med J SDU / SD
• Tıp Fak Derg u 2022:29(4):611-618 doi: 10.17343/sdutfd.1179733, Sozen M, Cetinarslan. B, Sevinc B

• Violin